- Home
- BATL vs PMN Comparison
BATL vs PMN Comparison
Compare BATL & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BATL
- PMN
- Stock Information
- Founded
- BATL 1987
- PMN 2004
- Country
- BATL United States
- PMN Canada
- Employees
- BATL N/A
- PMN N/A
- Industry
- BATL Oil & Gas Production
- PMN Pharmaceuticals and Biotechnology
- Sector
- BATL Energy
- PMN Health Care
- Exchange
- BATL Nasdaq
- PMN Nasdaq
- Market Cap
- BATL 19.3M
- PMN 22.3M
- IPO Year
- BATL N/A
- PMN N/A
- Fundamental
- Price
- BATL $1.09
- PMN $0.42
- Analyst Decision
- BATL
- PMN Strong Buy
- Analyst Count
- BATL 0
- PMN 3
- Target Price
- BATL N/A
- PMN $4.33
- AVG Volume (30 Days)
- BATL 411.5K
- PMN 3.1M
- Earning Date
- BATL 11-11-2025
- PMN 11-13-2025
- Dividend Yield
- BATL N/A
- PMN N/A
- EPS Growth
- BATL N/A
- PMN N/A
- EPS
- BATL N/A
- PMN N/A
- Revenue
- BATL $185,206,000.00
- PMN N/A
- Revenue This Year
- BATL N/A
- PMN N/A
- Revenue Next Year
- BATL N/A
- PMN N/A
- P/E Ratio
- BATL N/A
- PMN N/A
- Revenue Growth
- BATL N/A
- PMN N/A
- 52 Week Low
- BATL $1.01
- PMN $0.38
- 52 Week High
- BATL $6.89
- PMN $1.59
- Technical
- Relative Strength Index (RSI)
- BATL 43.38
- PMN 37.32
- Support Level
- BATL $1.02
- PMN $0.39
- Resistance Level
- BATL $1.21
- PMN $0.45
- Average True Range (ATR)
- BATL 0.08
- PMN 0.04
- MACD
- BATL 0.00
- PMN -0.01
- Stochastic Oscillator
- BATL 28.57
- PMN 16.71
About BATL Battalion Oil Corporation
Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.